{"url_path":"/sec/plx/8-k/2026-01-30/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-01-30","source_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-008410-index.html","accession_number":"0001104659-26-008410","cik":"0001006281","ticker":"PLX","issuer_name":"Protalix BioTherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-008410-index.html","primary_entity_key":"0001006281","primary_entity_name":"Protalix BioTherapeutics, Inc."},"word_count":78,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits**\n\n \n\nExhibit No.\n\n \n\nDescription\n\n[99.1](tm264565d1_ex99-1.htm)\n \n[Press Release dated January 30, 2026](tm264565d1_ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n** **\n\n****\n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: January 30, 2026\n\n**PROTALIX BIOTHERAPEUTICS, INC.**\n\n \n \n \n \n\n \nBy:\n/s/ Dror Bashan\n\n \n \nName:\nDror Bashan\n\n \n \nTitle:\nPresident and Chief Executive\nOfficer"}